可注射型人工骨联合撬拨复位穿针治疗跟骨骨折8例

回顾性分析2005-07/2006-11本科收治的单侧跟骨骨折患者8例,应用可注射型人工骨替代骨MIIG[R]X3联合经皮撬拨复位穿针固定治疗,根据美国足外科协会所制定的AOFAS踝与后足功能评分系统(总分100分)来评价术后患足功能.定期复查X射线片,观察材料及宿主反应,骨折愈合情况,肢体疼痛及关节活动情况.8例获得完整随访,并发症发生率为12.5%(1/8).Bohler角改善18°～25°,Gissane角改善30°～35°.8例患者中优6例,良2例,均获得骨性愈合.术后均未发生皮肤坏死,血肿、深部感染等并发症.

Injectable bone graft combined with percutaneous reduction by leverage for treatment of calcaneal fracture: 8 cases report

A retrospective analysis was performed among 8 patients with unilateral intraarticular calcaneal fracture, who were selected from the Department of Orthopaedics in Yangpu District Central Hospital of Shanghai. They were treated with the injectable bone graft MIIG[R] X3 combined with percutaneous reduction by leverage and axial fixation from June 2005 to November 2006. After treatment, the function of affected feet was evaluated according to the ankle-hindfoot score of the American Orthopaedic Foot & Ankle Society (totally 100 points). All the patients were rechecked with X-ray films periodically to observe the reaction between the materials and the host, the healing of fracture, the pain of limbs and joint motion. Eight patients were all followed up, the complication rate reached 12.5% (1/8), the improvement of Bohler angle excelled 18° to 25°, and that of Gissane angle exceeded 30° to 35°. Among the included patients, 6 cases achieved excellent effect and 2 cases good. All developed the bone union. None of all had complications, such as necrosis of skin, hematoma and deep infection.